Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01172873 · ClinicalTrials.gov registry record · NA

D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD

A NA study of Obsessive - Compulsive Disorder, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT01172873 is a NA study of Obsessive - Compulsive Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 16 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01172873, a NA study of Obsessive - Compulsive Disorder, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This is a single site, open-label, feasibility study of cognitive behavioral therapy with exposure and response prevention (CBT/ERP) adding the augmentation of D-cycloserine (DCS) for adolescents ages 12-17 with Obsessive Compulsive Disorder (OCD) who are partial or non-responders to first line treatments of CBT or pharmacotherapy.

Conditions Studied

Obsessive - Compulsive Disorder

Interventions

  • DRUG D-cycloserine
  • BEHAVIORAL Exposure and Response Prevention (EX/RP)

Study Locations (1)

New York

  • New York State Psychiatric Institute/Columbia University - New York

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2008-09
Est. Completion 2010-12
Phase NA

Sponsor

New York State Psychiatric Institute

364 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01172873

The ClinicalTrials.gov registry entry for NCT01172873 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 2 interventions - of which D-cycloserine is the first listed.

NCT01172873 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01172873 about?

NCT01172873 is a clinical study titled "D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD". This is a single site, open-label, feasibility study of cognitive behavioral therapy with exposure and response prevention (CBT/ERP) adding the augmentation of D-cycloserine (DCS) for adolescents ages 12-17 with Obsessive Compulsive Disorder (OCD) who are partial or non-responders to first line trea...

What is the current status of trial NCT01172873?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2008-09. Estimated completion is 2010-12.

What conditions does trial NCT01172873 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT01172873?

The interventions under investigation include: D-cycloserine (DRUG), Exposure and Response Prevention (EX/RP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01172873?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01172873 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obsessive - Compulsive Disorder

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.